Project Grant R34DE033630

Award Date 9/6/23
Completion Date 9/5/24
Dollars Obligated $312K
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
Michigan, USA
Similar Awards
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research federal grant program (CFDA 93.121), aims to develop and test a virtual patient-based learning (VPBL) methodology for improving dental education in temporomandibular disorders (TMD). The $105,450 award to Midwestern University, a private non-profit educational institution, will fund the establishment of interactive clinical scenarios incorporating...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), part of the Oral Diseases and Disorders Research program (CFDA 93.121), provides $738,929 to The Trustees of Columbia University in the City of New York to develop and validate a patient-specific TMJ-on-a-chip (TMJOC) model. The TMJOC will be used to investigate multi-tissue crosstalk regulating temporomandibular joint (TMJ) disc injury and healing under inflammation and pathophysiological...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $385,161 project grant on Sep 5, 2024 under the Oral Diseases and Disorders Research (CFDA 93.121) program to the Board of Regents of the University of Nebraska's University of Nebraska Medical Center (UNMC) Division. This grant aims to investigate the role of p21 positive senescent cells in obesity, aging, and trauma-induced temporomandibular joint (TMJ) degeneration, a painful and debilitating joint disease...
This Cooperative Agreement award, provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), will fund a $1,207,004 clinical trial to evaluate the safety and analgesic efficacy of a marine oil supplement in adults with chronic temporomandibular disorder (TMD) pain. The study aims to determine if the supplement, which contains precursors to specialized pro-resolving mediators, can reduce pain intensity,...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will provide $429,000.00 to the Regents of the University of Michigan to conduct research on the unique characteristics of jawbone biology. The research aims to gain a molecular-level understanding of how osteoblasts in the jawbone respond differently to bone morphogenetic protein (BMP) signaling and mechanical loading...
This federal Cooperative Agreement award, funded by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research grant program (CFDA 93.121), aims to conduct multi-omic investigations of temporomandibular joint (TMJ) disorders. The $587,428 award will support a two-phase project at the University of California, Los Angeles (UCLA) to: 1) develop protocols and infrastructure for data management, subject recruitment, and sample collection; and 2)...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $299,782 to develop and validate a novel Jaw Metabolic Stressor (JMS) task. The JMS task is designed to evoke targeted levels of jaw pain and fatigue in both chronic temporomandibular disorder (TMD) pain patients and healthy controls, in order to investigate the peripheral and central neural mechanisms...
The federal Cooperative Agreement award UH3DE032204 was granted by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research (CFDA 93.121) program. The $1,660,925.63 award supports a project at Thomas Jefferson University's Sidney Kimmel Medical College to utilize single-cell RNA sequencing to identify and classify cell populations and gene expression in temporomandibular joint (TMJ) synovial fluid from healthy and symptomatic TMJ...
This $222,500 Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will support research at The Children's Hospital of Philadelphia (CHOP) to investigate the pathogenic mechanisms of temporomandibular joint (TMJ) osteophyte formation. The key objectives are to test whether conditional ablation of the gene EXT1, which is involved in heparan sulfate synthesis, causes osteophyte formation...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), is providing $1,013,625 to the University of Pittsburgh to investigate the use of a porcine small intestine submucosa (SIS) scaffold for temporomandibular joint (TMJ) disc regeneration. The goal is to develop a safe and effective treatment for TMJ disc replacement, addressing the lack of FDA-approved options that leads to joint...

The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $312,000 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to the Regents of the University of Michigan Office of Research and Sponsored Projects to establish the Michigan Collaborative Hub for TMD Patient-Centric Research (MICH T PCR). The goal of the award is to transform the treatment of temporomandibular disorders (TMDs) through the translation of clinically-relevant innovations. The project aims to develop an organizational structure, ecosystem, and operational procedures to integrate basic and clinical TMD research, guide the most promising research toward clinical translation, and improve patient care. Key activities include establishing a multi-disciplinary team, integrating diverse research expertise, and formulating procedures to support the clinical translation of innovative TMD technologies and therapies. Upon completion, the University of Michigan will be positioned to advance basic and clinical TMD research, research training, and evidence-based treatment to address this significant public health issue.

Generated 7/16/24, 3:30 AM